Broadwood Capital Inc., 10% Owner at OncoCyte Corp (OCX), bought 600,000 shares at $4.50 ($2.7M) on 2021-02-05, disclosed to the SEC on 2021-02-09.
Open-market purchase of $2.7M OCX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| STAA | BUY | 2025-03-20 | $7.2M | — | Filing → |
| STAA | BUY | 2025-03-06 | $964K | — | Filing → |
| STAA | BUY | 2025-03-03 | $22.5M | — | Filing → |